IRAK4-IN-22 |
| Catalog No.GC69289 |
IRAK4-IN-22 (compound 18) es un inhibidor oral altamente efectivo y selectivo de IRAK4 con valores IC50 de 3 y 17 nM para IRAK4 y TAK1, respectivamente. IRAK4-IN-21 puede inhibir eficazmente la producción de IL-23 (IC50=0.10 µM), lo que lo hace útil en la investigación de enfermedades autoinmunitarias como psoriasis en placas y artritis psoriásica.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2170694-05-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for IRAK4-IN-22
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for IRAK4-IN-22
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *